We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$11.5B
AUM Growth
+$676M
Cap. Flow
+$423M
Cap. Flow %
3.68%
Top 10 Hldgs %
16.08%
Holding
1,352
New
79
Increased
457
Reduced
417
Closed
64

Top Buys

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$74.5M
2
SIVB
SVB Financial Group
SIVB
+$42.7M
3
WUBA
58.com Inc
WUBA
+$39M
4
CDK
CDK Global, Inc.
CDK
+$36.6M
5
AKAM icon
Akamai
AKAM
+$35.3M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$52.2M
2
BA icon
Boeing
BA
+$47.4M
3
HON icon
Honeywell
HON
+$43.6M
4
MSFT icon
Microsoft
MSFT
+$33.8M
5
TWX
Time Warner Inc
TWX
+$30.3M

Sector Composition

Rank Sector Weight
1 Technology 20.33%
2 Financials 17.82%
3 Healthcare 13.36%
4 Consumer Discretionary 10.96%
5 Industrials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGMO
1276
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$12K ﹤0.01%
850
+400
+89% +$6.64K
BLCM
1277
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$12K ﹤0.01%
161
– –
IBA
1278
DELISTED
Industrias Bachoco SAB De C.V.
IBA
$12K ﹤0.01%
200
– –
ADAP
1279
DELISTED
Adaptimmune Therapeutics
ADAP
$11K ﹤0.01%
950
– –
NBIX icon
1280
Neurocrine Biosciences
NBIX
$18.3B
$11K ﹤0.01%
110
– –
FOLD
1281
DELISTED
Amicus Therapeutics
FOLD
$10K ﹤0.01%
620
– –
THO icon
1282
Thor Industries
THO
$4.07B
$7K ﹤0.01%
70
– –
RDUS
1283
DELISTED
Radius Health, Inc.
RDUS
$7K ﹤0.01%
235
– –
ZYNE
1284
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$6K ﹤0.01%
650
– –
AKAO
1285
DELISTED
Achaogen Inc
AKAO
$6K ﹤0.01%
725
– –
SITC icon
1286
SITE Centers
SITC
$234M
$5K ﹤0.01%
539
-156,940
-100% -$1.56M
CPL
1287
DELISTED
CPFL Energia S.A.
CPL
$5K ﹤0.01%
420
– –
MDXG icon
1288
MiMedx Group
MDXG
$652M
$3K ﹤0.01%
514
-1,000
-66% -$7.12K
AAT
1289
American Assets Trust
AAT
$1.45B
– –
-8,320
Closed -$278K
ACLS icon
1290
Axcelis
ACLS
$3.57B
– –
-24,270
Closed -$597K
ACM icon
1291
Aecom
ACM
$9.44B
– –
-11,646
Closed -$415K
ANIK icon
1292
Anika Therapeutics
ANIK
$213M
– –
-6,607
Closed -$329K
ASB icon
1293
Associated Banc-Corp
ASB
$5.79B
– –
-48,307
Closed -$1.2M
ASH icon
1294
Ashland
ASH
$3.35B
– –
-50,426
Closed -$3.52M
BDN
1295
Brandywine Realty Trust
BDN
$514M
– –
-273,099
Closed -$4.34M
BKH icon
1296
Black Hills Corp
BKH
$5.55B
– –
-437
Closed -$24K
CAR icon
1297
Avis
CAR
$5.34B
– –
-27,584
Closed -$1.29M
CCRN
1298
DELISTED
Cross Country Healthcare
CCRN
– –
-8,007
Closed -$89K
CLDT
1299
Chatham Lodging
CLDT
$632M
– –
-22,781
Closed -$436K
CMPR icon
1300
Cimpress
CMPR
$2.37B
– –
-19,399
Closed -$3M
50 51
52
53 54

Similar funds

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
Mitsubishi UFJ Trust & Banking
Mitsubishi UFJ Trust & Banking Tokyo, Japan $40.6B AUM 25.18% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

KBC Group's Q2 2018 Portfolio in Review

As of Q2 2018, KBC Group held 1,352 positions worth $11.5B, up 6.2% from $10.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

KBC Group deployed $423M of net new capital in Q2 2018, opening 79 new positions and adding to 457 existing holdings. Its largest new stake was Broadcom: 432,730 shares worth $10.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $52.2M trimmed.

  • KBC Group's largest Q2 2018 buy was Broadcom: 432,730 shares worth $10.5M.
  • KBC Group added most to Cisco in Q2 2018, an estimated $74.5M increase.
  • KBC Group's biggest Q2 2018 reduction was AbbVie, cutting an estimated $52.2M.
  • KBC Group fully exited Time Warner Inc in Q2 2018, selling an estimated $30.3M.
  • KBC Group's ten largest holdings make up 16% of its $11.5B portfolio in Q2 2018.
  • KBC Group opened 79 new positions and closed 64 in Q2 2018.
  • KBC Group's portfolio value rose 6.2% quarter-over-quarter to $11.5B.

Based on KBC Group's 13F filing for Q2 2018, filed 3 Aug 2018.